DEA Temporarily Extends Telemedicine Prescribing of Controlled Substances - aamc.org
DEA temporarily extends telemedicine prescribing of controlled substances, providing continued flexibility for remote prescriptions.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on August 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, and e-prescribers that prescribe controlled substances via telemedicine. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the source; monitor DEA announcements for the exact expiration date.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The DEA has temporarily extended the ability to prescribe controlled substances via telemedicine, maintaining current flexibilities that were set to expire.
Who it affects
Telehealth platforms, virtual specialty clinics, behavioral-health providers, and e-prescribers that prescribe controlled substances via telemedicine.
What you must do
Review current telemedicine prescribing policies to ensure compliance with the temporary extension and prepare for potential future changes.
Deadline
Not specified in the source; monitor DEA announcements for the exact expiration date.
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- DEA publishes final rule on continuity of care via telemedicine for veterans - aasm.org
- DEA publishes final rule on expansion of buprenorphine treatment via telemedicine - aasm.org
- DEA Releases Rules on Telemedicine Prescribing of Controlled Substances, Proposes Special Registrations - jonesday.com
- DEA Allows VA Practitioners to Prescribe Controlled Substances via Telemedicine - aamc.org
- DEA Plans Special Registration for Telehealth Prescription of Controlled Substances - aamc.org